| Application no. and date | 15767597.6 (espacenet) (Federated) (European Patent Register), 20150908 | | Patent/reg. no. and date | DK/EP 3191120, 20240410 | | Publication date | 20170719 | | Priority no. and date | US 201462048512 P, 20140910 | | EP pub. no. and date |
EP 3191120 20170719 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V478215DK00 | | Inventor | RICHARDS, Hanno, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
MPOFU, Shephard, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
LIGOZIO, Gregory, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, NJ 07936, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/24 (2006.01) | | Title | Anvendelse af IL-17-antagonister for at hæmme progressionen af strukturel skade hos patienter med psoriasisgigt | | Int. application no. | IB2015056871 | | Int. publication no. | WO2016038538 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
